IBDEI1YJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34724,2)
 ;;=^5007831
 ;;^UTILITY(U,$J,358.3,34725,0)
 ;;=I80.221^^192^2009^19
 ;;^UTILITY(U,$J,358.3,34725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34725,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Popliteal Vein
 ;;^UTILITY(U,$J,358.3,34725,1,4,0)
 ;;=4^I80.221
 ;;^UTILITY(U,$J,358.3,34725,2)
 ;;=^5007835
 ;;^UTILITY(U,$J,358.3,34726,0)
 ;;=I80.231^^192^2009^20
 ;;^UTILITY(U,$J,358.3,34726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34726,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Tibial Vein
 ;;^UTILITY(U,$J,358.3,34726,1,4,0)
 ;;=4^I80.231
 ;;^UTILITY(U,$J,358.3,34726,2)
 ;;=^5007839
 ;;^UTILITY(U,$J,358.3,34727,0)
 ;;=I80.03^^192^2009^6
 ;;^UTILITY(U,$J,358.3,34727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34727,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Lower Extremity Superfic Vessels
 ;;^UTILITY(U,$J,358.3,34727,1,4,0)
 ;;=4^I80.03
 ;;^UTILITY(U,$J,358.3,34727,2)
 ;;=^5007823
 ;;^UTILITY(U,$J,358.3,34728,0)
 ;;=I80.02^^192^2009^12
 ;;^UTILITY(U,$J,358.3,34728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34728,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Left Lower Extremity Superfic Vessels
 ;;^UTILITY(U,$J,358.3,34728,1,4,0)
 ;;=4^I80.02
 ;;^UTILITY(U,$J,358.3,34728,2)
 ;;=^5007822
 ;;^UTILITY(U,$J,358.3,34729,0)
 ;;=I80.01^^192^2009^18
 ;;^UTILITY(U,$J,358.3,34729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34729,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Right Lower Extremity Superfic Vessels
 ;;^UTILITY(U,$J,358.3,34729,1,4,0)
 ;;=4^I80.01
 ;;^UTILITY(U,$J,358.3,34729,2)
 ;;=^5007821
 ;;^UTILITY(U,$J,358.3,34730,0)
 ;;=I80.9^^192^2009^21
 ;;^UTILITY(U,$J,358.3,34730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34730,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Unspec Site
 ;;^UTILITY(U,$J,358.3,34730,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,34730,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,34731,0)
 ;;=R91.8^^192^2010^2
 ;;^UTILITY(U,$J,358.3,34731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34731,1,3,0)
 ;;=3^Abnormal Lung Field Findings
 ;;^UTILITY(U,$J,358.3,34731,1,4,0)
 ;;=4^R91.8
 ;;^UTILITY(U,$J,358.3,34731,2)
 ;;=^5019708
 ;;^UTILITY(U,$J,358.3,34732,0)
 ;;=R63.4^^192^2010^3
 ;;^UTILITY(U,$J,358.3,34732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34732,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,34732,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,34732,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,34733,0)
 ;;=R10.0^^192^2010^4
 ;;^UTILITY(U,$J,358.3,34733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34733,1,3,0)
 ;;=3^Acute Abdomen
 ;;^UTILITY(U,$J,358.3,34733,1,4,0)
 ;;=4^R10.0
 ;;^UTILITY(U,$J,358.3,34733,2)
 ;;=^885
 ;;^UTILITY(U,$J,358.3,34734,0)
 ;;=M80.08XA^^192^2010^58
 ;;^UTILITY(U,$J,358.3,34734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34734,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/ Vertebra Fx,Init Encntr
 ;;^UTILITY(U,$J,358.3,34734,1,4,0)
 ;;=4^M80.08XA
 ;;^UTILITY(U,$J,358.3,34734,2)
 ;;=^5013495
 ;;^UTILITY(U,$J,358.3,34735,0)
 ;;=K52.2^^192^2010^5
 ;;^UTILITY(U,$J,358.3,34735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34735,1,3,0)
 ;;=3^Allergic/Dietetic Gastroenteritis/Colitis
 ;;^UTILITY(U,$J,358.3,34735,1,4,0)
 ;;=4^K52.2
 ;;^UTILITY(U,$J,358.3,34735,2)
 ;;=^5008701
 ;;^UTILITY(U,$J,358.3,34736,0)
 ;;=R63.0^^192^2010^6
 ;;^UTILITY(U,$J,358.3,34736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34736,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,34736,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,34736,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,34737,0)
 ;;=R09.01^^192^2010^7
 ;;^UTILITY(U,$J,358.3,34737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34737,1,3,0)
 ;;=3^Asphyxia
